Sargent Bickham Lagudis LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 50 shares of XBI stock, worth $5,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$5,060% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding XBI
# of Institutions
894Shares Held
94.6MCall Options Held
18.4MPut Options Held
31.6M-
Jpmorgan Chase & CO New York, NY12.3MShares$1.25 Billion0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY12MShares$1.21 Billion0.19% of portfolio
-
Bank Of America Corp Charlotte, NC8.98MShares$909 Million0.07% of portfolio
-
Citigroup Inc7.26MShares$735 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.41MShares$649 Million0.05% of portfolio